Chemical compounds studied in this article: 1. Holadysamine 2. Holaphyllinol a b s t r a c t Ethnopharmacological relevance: Buruli ulcer (BU) is the third most common mycobacterial infection in the world, after tuberculosis and leprosy and has recently been recognized as an important emerging disease. This disease is common in West Africa where more than 99% of the burden is felt and where most affected people live in remote areas with traditional medicine as primary or only option. Reports indicate that the ethnopharmacological control approach of the disease in such settings has shown promise. However, no or very few compilations of traditional knowledge in using medicinal plants to treat BU have been attempted so far. This review aimed to record medicinal plants used traditionally against BU in three countries in West Africa: Ivory Coast, Ghana and Benin and for which ethnopharmacological knowledge supported by pharmacological investigations has been reported. The information recorded in this review will support further pharmacological research to develop appropriate drugs for a better BU control. Material and methods: A systematic review of the literature on ethnobotanical use and anti-BU activity of plants reported for BU treatment was performed. The approach consisted to search several resources, including Technical Reports, Books, Theses, Conference proceedings, web-based scientific databases such as publications on PubMed, Science direct, Springer, ACS, Scielo, PROTA, Google and Google scholar reporting ethnobotanical surveys and screening of natural products against Mycobacterium ulcerans. This study was limited to papers and documents published either in English or French reporting ethnopharmacological knowledge in BU treatment or pharmacological potency in vitro. This review covered the available literature up to December 2014. Results: The majority of reports originated from the three most affected West African countries (Cote d'Ivoire, Ghana and Benin). Though, 98 plant species belonging to 48 families have been identified as having anti-BU use, many have received no or little attention. Most of the pharmacological studies were performed only on 54 species. To a lesser extent, ethnopharmacological knowledge was validated in vitro for only 13 species. Of those, seven species including Ricinus comminus, Cyperus cyperoides (cited as Mariscus alternifolius), Nicotiana tabacum, Mangifera indica, Solanum rugosum, Carica papaya, and Moringa oleifera demonstrated efficacy in hospitalised BU patients. Four isolated and characterized compounds were reported to have moderate bioactivity in vitro against M. ulcerans. Conclusions: This review compiles for the first time ethnopharmacologically useful plants against BU. The phamacological potential of 13 of them has been demonstrated in vitro and support BU evidence-based traditional medicines. In addition, 7 species showed activity in BU patients and have emerged as a promising source of the traditional medicine for treatment of BU. Yet, further safety and efficacy study should be initiated prior any approval as alternative therapy. Overall, a huge gap in knowledge appeared,
Introduction
Buruli ulcer (BU) is a necrotizing disease of the skin, subcutaneous tissue and bone and it is caused by the environmental pathogen Mycobacterium ulcerans. This disease is the third most common mycobacterial infection in the world, after tuberculosis and leprosy (WHO, 2011) . The pathogenesis of BU is associated with mycolactone, a lipidic exotoxin produced by M. ulcerans that has cytotoxic and immunosuppressive properties (Martins et al., 2012) . It is largely a problem of people living in remote rural areas. How exactly M. ulcerans is transmitted to humans remains unknown, but in contrast to tuberculosis or leprosy, the infection is acquired directly or indirectly from the environment and not through contact with other patients (Stinear and Johnson, 2008) . At least 33 subtropical and temperate countries have reported cases of BU. Fifteen of these countries have reported 5000-6000 annual cases. In Asia and the Western Pacific, most cases occur in tropical and subtropical regions except in Australia, China and Japan. In West Africa, Benin, Ivory Coast and Ghana reported most of the cases of which almost half occurred in Ivory Coast (WHO, 2013) . According to WHO, Africa bears 99% of the global burden of this disease.
Early reports have suggested that wide surgical excision was the only effective treatment (MacCallum et al., 1948) for BU and also, early trials with clofazimine (Revill et al., 1973) in the antibiotic era demonstrated only marginal benefits. In 2005, the WHO introduced new provisional antibiotic treatment guidelines for BU following a successful pilot study from Ghana which confirmed that human lesions can be sterilised with antibiotics (Etuaful et al., 2005) . This was supported by encouraging reports of success with the protocol in a series of cases from Benin (Chauty et al., 2007) . The WHO protocol has led to a new approach to treatment with the potential to reduce cost, to allow delivery of care closer to the homes of patients, and to encourage patients to present earlier as the fear of requiring major surgery is lessened. The combination treatment protocol involves oral intake of Rifampicin, 10 mg/kg body weight daily for 8 weeks plus Streptomycin, 15 mg/kg body weight by intramuscular injection daily for 8 weeks. Although recent experience indicates that combination chemotherapy with Streptomycin and Rifampicin improves cure rates, the utility of this regimen is limited by the 56 days duration of treatment, potential toxicity and required parenteral administration of streptomycin (Johnson, 2010; Zhang et al., 2013) . In addition drug-drug interactions caused by Rifampicin (Chauty et al., 2007; Johnson, 2010; Zhang et al., 2013) and the indirect cost to family due to the long stay associated with the economic burden limit this protocol. On the other hand, surgery, which is however necessary for some severe forms of the disease (large ulcerated forms, disseminated forms, and osteomyelitis) to correct deformities and improve wound healing (Kibadi et al., 2010 ) is neither affordable nor accessible to a large proportion of the population (Johnson et al., 2004) . Furthermore, although BU is a treatable disease, its burden is increasingly felt due to inappropriate control measures and poor emphasis in developing new anti-BU drugs.
Because of cultural believes and/or budgetary constraints, traditional plant-based treatments remain the first option for many populations in poor remote areas (Johnson et al., 2004) . For poor and sick persons, modern treatment is not only expensive, but is also subject to side effects, mutilation and amputation (Stienstra et al., 2002) . Reports have indicated that plant products selected based on traditional knowledge might be of great importance in the early treatment and prevention of BU at an affordable cost. However, there remain huge gaps in knowledge about the real efficacy of potions, their standardization, and active principles. The scope of this review is a survey of current knowledge on medicinal plants used traditionally to treat BU and for which ethnopharmacological reports supported by pharmacological data have been documented. It is anticipated that information recorded herein will support further detailed investigations opening on improved tools for better control of BU and eventually other mycobacterial infections.
The data presented here were obtained from web-based search of publications on PubMed, Science direct, Springer, ACS, Scielo, Google and Google scholar databases reporting ethnobotanical uses and screening of natural products against BU using the keywords "medicinal plants þBuruli ulcer", "ethnobotanical þBuruli ulcer", "natural products", "antimycobacterial screening", "Buruli ulcer", "M. ulcerans", "mycobacteria", and "Traditional medicine þ Buruli ulcer". In addition, Technical Reports, Books, Theses, and Conference proceedings were study. This literature survey was limited to papers and documents published either in English or French. All retrieved information from documents reporting either ethnopharmacological knowledge in BU treatment or pharmacological potency in vitro against M. ulcerans is discussed here. This review covers the available literature up to December 2014. All plant species have been validated taxonomically with www.theplantlist.org (accessed December 2014).
Ethnopharmacological use of plants to control BU
Globally, the proportion of the populations using traditional remedies based on plants to treat BU varies widely. Mostly in the rural African areas, the use of plant medicines plays an important role in daily health care. These medicines are sometimes preferred to modern medicines. Generally, specialized pharmacopoeia is practiced by traditional healers, and the popular or general pharmacopoeia is common knowledge in specific communities. From data collected in the framework of this review, parts or whole plants are prepared and administered per os and/or locally as pomade and bandage. Most remedies are mixtures of parts of two or more plant species and water is the main solvent.
Generally, traditional treatment for BU is done in four steps, diagnosis, necrosis ablation, wound curing, and exorcism. Plants are used in the second and third steps of treatment (Johnson et al., 2004 (Sam et al., 2013; Yemoa et al., 2008; Addo et al., 2007; Vangah et al., 2000) , observation and focus group discussions Adjet et al., 2013) , and subsequent experimental investigation of indigenous medicines based on determination of in vitro activity as an approach to drug discovery. Indeed, the majority of studies reported in this paper were carried out in Health centres specifically dedicated to the treatment of Buruli ulcer; providing almost certainly a guarantee that they were all affected by this pathology. The identity of plants is usually authenticated by competent authorities such Botany department or herbarium. Limitations to the interview approach might be the reluctance of some herbal practitioners to disclose plants names and combinations. Moreover, potions trials on BU patients was of good quality as it provided direct evidence of efficacy with a complete pattern of the disease .
Extraction and isolation
Extraction methods generally mimic herbal practitioners' approach to prepare decoctions or infusions using mainly water and palm wine (Yemoa et al., 2015 (Yemoa et al., , 2011 Addo et al., 2007; Kone et al., 2007 Kone et al., , 2009 ). Other extraction procedures include the use of ethanol or organic solvents of increasing polarity (hexane, dichloromethane, ethyl acetate and water) to partition plant materials. Isolation of active principles generally follows a bio-guided chromatographic fractionation approach (Yemoa et al., 2015) . The characterization of isolated compounds is performed using physical and spectroscopic techniques.
Antimicrobial assays
Antimicrobial activity testing assays are generally performed using cultured M. ulcerans strains and isolates. Rifampicin is usually incorporated as positive control (Yemoa et al., 2015) . Susceptibility assays are conducted using the proportion method where inhibitors are incorporated into Löwenstein-Jensen media at defined concentrations (Addo et al., 2007; Coulibaly et al., 2011; Kone et al., 2007) , or the resazurin method on microtitre plate format where mycobacteria are incubated with inhibitors in supplemented Middlebrook 7H9-S broth (Yemoa et al., 2011 (Yemoa et al., , 2015 . In all cases, activity is usually defined as minimal inhibitory concentration (MIC) considered as the lowest drug concentration that inhibits the growth of at least 99% of mycobacteria in culture relative to negative control.
Toxicity studies
Toxicity studies were not considered in all retrieve information, but for the sake of providing holistic information on medicinal plants used, data on toxicity of plants that showed activity either in vitro or on BU patients are provided and they are often conducted in rodent models.
The present review has identified plants that are reported to be used to treat BU (Table 1) . Some of these plants have undergone various degrees of scientific investigation, including testing on patients. In the following subsections, plants which have been investigated so far as potential sources of therapy against BU are presented.
2.1.5. Traditional medicine reports 2.1.5.1. Places and frequency of citation of plant species. The review has identified 98 plant species belonging to 88 genera and 48 plant families that are used for the treatment of BU or related symptoms. Places and frequency of citation of species used to treat BU are summarized in Table 1 .
Most of the cited plants were from Benin, Ivory Coast, and Ghana (Table 1 , Fig. 1 ) where 79 species were individually reported in only one country, including 35 in Ghana, 32 in Benin and 12 in (Fig. 1) .
Cassia alata L., Bauhinia thonningii (cited as Piliostigma thonningii), Ocimum gratissimum (cited as Ocimum viride), Vernonia amygdalina, Chromolaena odorata, Carica papaya, Periploca nigrescens (cited as P. nigrescens), Alstonia boonei, Mangifera indica, and Dysphania ambrosioides (cited as Chenopodium ambrosioides) (2) Many others were cited only once. The plant families with more cited species included Apocynaceae and Euphorbiaceae (7), Leguminosae (6), Solanaceae (5), Phyllanthaceae (4), Anacardiaceae, Annonaceae, Bignoniaceae, Compositae, Lamiaceae, Meliaceae, Poaceae, and Rutaceae (3), Araceae, Arecaceae, Capparaceae, Combretaceae, Malvaceae, Moraceae, Musaceae, Rubiaceae, Xanthorrhoeaceae and Zingiberaceae (2). The other plant families were represented by only one species as shown in Table 1 .
Cultural believes are comparable in West Africa, especially between Ivory Coast and Ghana who are neighbouring countries, and Benin. It should also be emphasized that diversity of floras is shared by these nations. Plants citation frequency was therefore expected to corroborate this pattern. The observed disparities highlight a concern about the reports contents that might indicate a lack of credibility, or otherwise a rich biodiversity of medicinal plants with anti-BU potential. This latter option might underline a poor documentation of plants of interest for BU control, and therefore indicates that more interest and emphasis should be developed in this line, especially by local governments and scientists.
2.1.6. Recipes reports 2.1.6.1. Preparation of ethnopharmacological recipes for BU control. The ethnopharmacological data including plant parts used, methods of preparation and administration of potions are shown in Table 1 . The repartition of forms of herbal preparations and routes of administration and dosage of prescribed herbal remedies are shown in Figs. 2 and 3 , respectively. The preparation of the medicines employed several methods, decoction (27%), followed by trituration (20%), infusion (15%), powders (12%), pomade and maceration (10%). Of note, decoction and trituration are the fastest approaches when it comes to potions taken orally or applied to wounds.
Some of these preparations were made from mixtures of different plant species and used for the treatment of BU: Manihot esculenta and V. amygdalina; Gossypium hirsutum, Physalis angulata, Delonix regia and Jatropha curcas; C. papaya and Xylopia aethiopica; Citrus aurantifolia and Spathodea campanulata; Gossypium barbadense, Albizia zygia and Momordica charantia; and Spigelia anthelmia and Zea mays (Addo et al., 2007; Sam et al., 2013; Adjet et al., 2013; Seefeld et al., 2013; Trébissou et al., 2014) .
Leaves were the most frequently used plant part (53), followed by root (22), fruit/seed (12), and stem bark/bark (11).
Routes of administration and dosage prescription of herbal remedies
Bandage or dermal administration (42 citations) was the predominant route of administration followed by oral administrations (5 citations). The choice for bandage or dermal administration is consistent given that BU usually starts with painless, raised skin lesion or papule that may extend from the skin into the subcutaneous tissue. Therefore, it becomes a serious concern for rural populations when the oedema breaks down to form an ulcerated wound that needs bandage and healing. Decoction, infusion, or maceration were reported as taken orally or used to wash or disinfect the wound while powders, trituration, and ointments were applied on the ulcer as bandages (Table 1 ).
Very few reports described dosage prescriptions and generally recommendations were to administer the herbal remedies twice or thrice daily during 3 days to many months or continued until recovery. The problems associated with dosage used in herbal remedies prescription have been repeatedly highlighted (Tsabang et al., 2012; Asase et al., 2010) . In fact, the inadequate knowledge about herbs and their likely contribution to health makes the herbal dosage concept difficult to understand. It is generally believed in settings where traditional herbal medicine is keen that the pharmacological effect of herbs is due to their pretended active and "safe" components that will only exert quick effect when taken in large amounts. Almost all the reports made no mention of possible side effects. But this could be anticipated as most traditional healers do not, broadly speaking, know of the probable and significance of side effects of their herbal remedies.
Overall, plant potions are mainly used during necrosis ablation and wound healing phases of treatment (Johnson et al., 2004) . Different plant parts are used under various recipes administered by oral or topical route. The survey reports identified many recipes, the most cited including decoction, maceration, powder, carbonisation, trituration, pomade, and infusion (Table 1) . Many other plants that are not described in this review have been reported in BU treatment and against skin ulcers without any description of recipes. In many occasions, detailed information about herbal remedies dosage were not specified, but only the plant name and route of administration and the outcome were mentioned.
2.1.8. Potency of herbal remedies in patients with Buruli ulcer and toxicity A total of 7 species: Ricinus comminus, Nicotiana tabacum, M. indica, C. papaya, Solanum rugosum, Cyperus cyperoides (cited as Mariscus alternifolius), and Moringa oleifera have been administered to patients and the outcome followed up. The first clinical study based on 6 plants used to treat BU was conducted in three Buruli ulcer caring and management centers in Ivory Coast. Three preparations were used, including maceration of R. comminus and N. tabacum, infusion of M. indica and C. papaya, and powder for S. rugosum and C. cyperoides that were applied twice or thrice a day on the ulcer. Of a study population of 273 patients, 219 (80%) were healed (with N. tabacum, M. indica, S. rugosum and C. papaya), while 41 (15%) had their ulcer stabilized (with R. comminus and C. cyperoides) and 13 (5%) felt no effect after treatment. This study highlighted the beneficial potential of the used herbs remedies . In the second study, a trial in two groups of 15 children (2-15 years) attending the Centre St Pio Padio, Ivory Coast and each having clinical forms of BU showed that after six weeks of treatment, children receiving normal diet supplemented with 330 mL of aqueous extract of M. oleifera leaves per meal, had a higher rate of healing compared to children under normal non supplemented diet (Kodia et al., 2014) . The results achieved by the authors emphasize the added value of supplementation of the diet with M. oleifera extract. Meanwhile, understanding the mechanism of efficacy of this medicine could be helpful in the therapy of BU. Moreover, such beneficial effect should be validated through more detailed investigations of the added extract, specifically its action against the causative mycobacterial agent or other values such as anti-oedematous, anti-inflammatory, sedative, wound healing, immune inhibition, and inhibition enzymes involve mycolatone production.
On another hand, close collaboration between herbal practitioners and modern physicians and other health professionals should be effective to help tackle the impact of the disease in endemic regions (Johnson et al., 2004; Renzaho et al., 2007) . However, no detailed safety studies were conducted prior to these trials.
To a certain extent, these plants that were reportedly used in clinical settings to treat BU have undergone safety studies.
Ricinus communis intoxications in humans and animals have been known for centuries and it is attributed mainly to the toxicity of ricin, haemagglutinin and ricinine (Worbs et al., 2011) . The seeds are the most toxic part of the plant although the leaves are also poisonous. The inhalational toxicity (in estimated LD 50 ), for two different R. communis cultivars in rats has been reported to be between 3.7 mg/kg and 9.8 mg/kg body weight. In non-human primates, the LD 50 after inhalational application was found to be 5.8 mg/kg for African green monkeys and 15 mg/kg for rhesus monkeys. The least toxic route is oral uptake or intra-gastric delivery and is about 1000 times less toxic than parenteral injection or inhalation. For mice, LD 50 values of 21.5 mg/kg and 30 mg/kg were reported (Worbs et al., 2011) . In clinical reports, the number of seeds ingested causing mild to severe symptoms, including a fatal outcome, range from uptake of only single seed to up to 30 seeds (Worbs et al., 2011 ).
Crushed leaves of N. tabacum that are applied on wounds contain nicotine, malic and citric acids, phenolic acids, flavonoids, coumarins and enzymes (Lans et al., 2001 ). An oral LD 50 of 50 mg/ kg body weight was observed in rats with no significant effects on hematocrit and bleeding time following 6 weeks of oral administration (Ukoha et al., 2012) . Meanwhile, The increase in biochemical parameters such as: transaminases and alkaline phosphatase activities suggested that it may be associated with liver toxicity at up to 600 mg/kg (Nweze et al., 2015) .
The administration of the aqueous decoction from leaves of M. indica up to a dose of 5000 mg/kg (per os) did not produce any signs or symptoms of toxicity in treated male Swiss albino mice (Severi et al., 2009) . At this dose range, the extract can be categorized as safe. It is also documented that the acute toxicity (LD50) of M. oleifera aqueous extract of 16,100 mg/kg and ethanol extract of 39,800 mg/kg are within the safe range (Kasolo et al., 2012a) . The oral daily administration of LD50 dose of M. oleifera leaves aqueous extract for 30 days shows features of mild sub-acute toxicity and indicates safer outcomes (Kasolo et al., 2012b) . In another study, acute toxicity studies of M. oleifera leaves extract in rats showed no mortality at doses range of up to 2000 mg/kg. However, M. oleifera is genotoxic at supra-supplementation levels of 3000 mg/kg. In a sub-acute toxicity study, oral treatments in rats for 21 days with this extract at 400, 800 and 1600 mg/kg caused varied significant changes in haematological parameters that could be attributable to the presence of isothiocyanate producing glycosides (Adedapo et al., 2009) . However this results have little scientific significance given the contradiction with the previously mention findings. The subchronic treatment of Sprague Dawley rats for 13 weeks with the leaf extract of C. papaya showed no significant toxicity effect at doses up to 2000 mg/kg, many orders of magnitude above the levels employed in traditional medicine (Ismail et al., 2014) . Within the framework of this literature survey, no report on toxicity study on C. cyperoides and S. rugosum was found.
Anti-BU plants: In vitro potency, phytochemistry, and toxicity
Many plants with claimed anti-BU potential have undergone various degrees of scientific investigations as evidenced in this review. Briefly, reported scientific investigations include botanical identification and plant collection, aqueous/organic extraction and in vitro testing against M. ulcerans, the causative agent of BU. Generally, active extracts are further fractionated on a bio-guided basis using chromatographic techniques to isolate the bioactive natural products. In the following subsections, data reported on in vitro potency against M. ulcerans of 13 species (including a mixture of two species; tonic 1) used in traditional treatment of BU are presented (Table 2 ). In addition, reported phytochemical and toxicological data on plants as well as isolated active compounds are presented.
Aglaonema commutatum Schott.
A. commutatum is an erect herbaceous common ornamental plant that is used to treat BU. Extract from this plant showed anti-M. ulcerans activity with MIC value of 40 mg/mL (Table 1) (Addo et al., 2007) . Leaves juice was reported to be used to heal wounds. It was also shown to exhibit inhibitory effects on Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus commonly involved in burns and wound infections that can account for its anti-BU potential. Very few studies have been reported on this plant. The main report referred to its poisonous crystals and its use as ornamental plant. All parts of the plant contain calcium oxalate crystals that can cause inflammation and irritation of the gastrointestinal tract with some fatalities reported (Fuller and McClintock, 1986 ).
Aloe vera (L.) Burm. f.
A. vera is a perennial plant widely used for the treatment of various ailments including BU (Addo et al., 2007; Seefeld et al., 2013) . Leaf extract showed MIC value of 40 mg/mL (Table 2) (Addo et al., 2007) on M. ulcerans. Numbers of its chemicals have been identified such as carbohydrate polymers; glucomannans, phenolic compounds such as chromone and anthraquinone. Naturally the gel is used for its wound healing potential as its high content in water can keep the wound moist and promote epithelial cell migration. In addition, the main carbohydrate, mannose 6-phosphate, has been suggested to play a significant role in the wound healing potential of A. vera gel (Davis et al., 1994; Bruneton, 1995) . In fact, the binding of mannose 6-phosphate to the growth factor receptors on the surface of the fibroblasts increases both collagen and proteoglycan synthesis that directly stimulates macrophages and fibroblasts resulting in tissue reparation. Similarly, acemannan purified from leaves, has showed to accelerate wound healing and reduce radiation induced skin reactions through macrophage activation and consequently may stimulate the release of fibrogenic cytokines otherwise growth factors may directly bind to acemannan and promote their stability and extend the stimulation of granulation tissue. Genin, a saponin contained in A. vera, has also been reported as involved in wound healing activity (Mukherjee et al., 2014; Davis et al., 1994; Bruneton, 1995) . Studies of the growth of normal human cells in vitro demonstrated that cell growth and attachment were promoted by exposure to fresh A. vera leaves, whereas a stable gel preparation was shown to be cytotoxic to both normal and cancer cells. However, the cytotoxic effects of the gel were thought to be due to the addition of other substances to the gel during processing (Winters et al., 1981) . Treatment over 6 months with A. vera in rats did not induce tolerance in the sense of a reduced laxative effect. Meanwhile, prolonged use or overdosage may cause nephritis, vomiting, bloody, mucus, or watery diarrhoea leading to electrolyte imbalance and hemorrhagic gastritis. A. vera gel has been reported to cause contact and photo dermatitis or erythema with papulous when administered on the skin, despite its anti-inflammatory potential and ability to heal wounds. In ten control trials involving 803 subjects no withdrawals or significant side reactions was observed, and the benign adverse reactions mainly involved burning after topical application, contact dermatitis and mild itching. All adverse effects were reversible and A. vera was generally well tolerated (Mukherjee et al., 2014) .
Alstonia boonei De Wild.
Alstonia is a widespread genus of evergreen trees and shrubs. The leaves paste of A. boonei is used for daily bandage of washed ulcer in BU treatment. Addo et al. (2007) reported it to have activity in vitro against M. ulcerans with MIC value of 40 mg/mL (Table 1) . This plant known for its wound healing properties contains complex polysaccharides in abundance, mainly mucilages but also alkaloids, tannins, steroids, saponins, glycosides, flavonoids, triterpenoids, and terpenoids (Chime et al., 2013; Igbinaduwa and Obasuyi, 2012) . This diversity of bioactive secondary metabolites found in this plant might sustain its effect against BU. The acute toxicity dose of the ethanolic and methanolic extracts (root & bark) of A. boonei was shown to be above 5000 mg/kg body weight (Iyiola et al., 2011; Onwusonye et al., 2014) . Histological examination of liver sections of mice also showed relatively normal histological features (Onwusonye et al., 2014) . The stem bark hydroethanolic extract showed no effect in guinea-pigs kidney at 50 and 200 mg/kg following 2 weeks of treatment. On another hand, extract dose of 200 mg/kg significantly raised blood urea, creatinine, potassium, and chloride ions levels by the 4th week and the kidney cells showed obvious histological signs of potential toxicity (Oze et al., 2006) , indicating that A. boonei potions should be taken with caution.
Capsicum annum L.
C. annum is a perennial shrub, with woody trunk which bears green fruits that ripen to red. The fruits are widely known in tropical Africa where they are largely used as spices for pepperish taste. The maceration of fruit is used for BU treatment and has showed MIC value of 40 mg/mL on 7 M. ulcerans isolates (Table 2 ) (Addo et al., 2007) . A phytochemical study of C. annum established the presence of reducing compounds, saponins, alkaloid salts, alkaloids, quarternary bases, anthracenosides, flavanosides, Table 2 Bioactive plants used in the traditional treatment of Buruli ulcer.
Species
Extract origin (2007) w/v ¼20% w/v (200 mg/mL) of herbal preparations (infusions, decoctions and juices) were each incorporated at 1:5 dilution into L-J medium corresponding to a final concentration of 40 mg/mL. V/V ¼ ; The herbal preparations that exhibited anti-M. ulcerans activity were incorporated into L-J media at two-fold serial dilutions (1st to 8th dilution). For MICs, consequently, the infusions, decoctions and juices at 20% w/v were incorporated into L-J media at final concentrations ranging from 25% vol/vol to 0.20% vol/vol corresponding to 50 mg/mL to 0.4 mg/mL (Addo et al., 2007) .
flavonoids, coumarin derivatives, steroid glycosides and anthocyanosides (Lagu and Kayanja, 2013) . C. annum also contains a complex mixture of essential oils, waxes, coloured materials (mainly capsanthin, capsorubin, zeaxanthin, cryptoxanthin, and lutein), and several capsaicinoids (Wesołowska et al., 2011) . Study by Lagu and Kayanja (2013) In addition, haemorrhage of the gastric fundus was observed in some of the animals that died. Intravenous, intraperitoneal, and subcutaneous LD 50 values were lower. In subchronic oral toxicity studies using mice, capsaicin produced statistically significant differences in the growth rate as the liver/body weight increased (Cosmetic Ingredient Review Expert Panel, 2007) . Capsaicin is an active component of chili peppers, which are plants belonging to the genus Capsicum. It is an irritant for mammals, including humans, and produces a sensation of burning in any tissue with which it comes into contact. Capsaicin is used as an analgesic in topical ointments, nasal sprays, and dermal patches to relieve pain. These beneficial features of capsaicin if well managed, could add value to the use of medicinal plants to control BU.
2.2.5. Jatropha curcas L. J. curcas is a tree that is reportedly used in traditional medicine to cure BU. Its leaf ethanolic extract inhibited the growth of M. ulcerans with MIC value of 250 mg/mL. Numerous biologically active compounds have been isolated and characterized from all parts of this plant including flavanoids, apigenin, vitexin, isovitexin, sterol, stigmasterol, β-D-sitosterol, β-D-glucoside, sapogenins, alkaloids, triterpenae alcohol and 1-triacontanol (Prasad et al., 2012) . The latex contains proteolytic enzymes that have been suggested to provide significant wound healing activity (Lans et al., 2001) . Although fatalities with Jatropha poisoning are rare, Abdu-Aguye et al. (1986) demonstrated that oral seeds administered to mice can cause macroscopic anal haemorrhage and death. They also found that extract of the seed administered intraperitoneally in mice can cause death in doses as low as 1 mg/kg (Abdu-Aguye et al., 1986) . Singhal et al. (2013) studied the clinical and biochemical profiles of eight children with J. curcas poisoning and observed lethargy, severe abdominal pain, inability to ingest, and intense thirst amongst the most prominent complaints in all children (Singhal et al., 2013) .
2.2.6. Holarrhena floribunda (G.Don) T. Durand H. floribunda grows as a shrub or tree (Yemoa et al., 2008) and is used to treat BU. Yemoa et al. (2011) reported that H. floribunda root ethanol extract inhibited the growth of M. ulcerans with MIC value of 125 mg/mL. The methylene chloride fraction of this extract containing alkaloids also inhibited the growth of M. ulcerans with an MIC value of 125 mg/mL as well as the alkaloid-rich extract (MIC ¼62.5 mg/mL). Chemical compounds isolated from H. floribunda include holaphylline, holaphyllamine, holamine, holaphyllinol, holaphyllidine, holadysamine, holarrhesine, conessine, and progesterone (Yemoa et al., 2015) . Holamine, holaphyllamine and holaphylline showed significant anti-inflammatory properties that can add value to the anti-BU properties. They cause sodium retention and act as diuretics in rats. Aqueous extracts of root bark, stem bark and leaves showed relatively low toxicity (Schmelzer, 2006) . Overall, the bioactive components isolated from this plant support its use in traditional medicine to treat BU.
2.2.7. Sacoglottis gabonensis (Baill.) Urb.
S. gabonensis is a tropical rain forest tree used in traditional medicine to treat BU. The stem bark decoction is taken orally or used for disinfection of ulcer or covered with fine powder as bandage. Its aqueous extract showed promising activity against M. ulcerans in vitro (MIC¼780 mg/mL) (Kone et al., 2007) (Table 2 ). The phytochemical screening of its stem bark extract showed the presence of sterols, polyterpenes, polyphenols, flavonoids, tannins, saponins and alkaloids. Sofowora (1996) also reported that these compounds are responsible for the biological activities of a plant. The acute and subacute toxicity studies of the aqueous extract of this plant showed a LD 50 value of 5000 mg/kg in mice per os whereas a 28 day administration of up to 350 mg/kg/day did not significantly influence haematological and biochemical parameters (Kone et al., 2009 ).
Solanum torvum Sw.
S. torvum is a commonly used herb in traditional medicine that possesses antiulcer activity (Agrawal et al., 2010) . The antimicrobial properties of its leaves have been reported in Gabon for cuts and wounds (Schippers, 2004) . Its leaf decoction that is used to treat BU has been reported to act against M. ulcerans with MIC value of 40 mg/mL (Table 1) (Addo et al., 2007) . S. torvum revealed the presence of flavanoids, alkaloids, sterols and triterpenes which may be responsible for anti-ulcer property (Agrawal et al., 2010) . This plant also contains number of steroidal glycosides among which torvoside A-H are considered to be furostanol glycosides. Torvoside M and N have antimicrobial activity and cytotoxic effect on PC-12 and HCT-116 cell lines. Non alkaloidal constituents like tetratriacontanoic acid, sitosterol, stigmasterol and campesterol have also been isolated and identified from S. torvum leaves (Agrawal et al., 2010) . Acute intoxication with poisonous S. torvum berries appears to cause toxic myopathy. The constituents directly responsible for this effect remain unknown; however, there is a higher likelihood of the class of solanaceous steroidal glycoalkaloids. Indeed, steroid glycoalkaloids inhibit serum and erythrocyte acetylcholinesterase and butyrylcholinesterase and lead to clinical manifestations including gastrointestinal distress, cranial nerve abnormalities, and respiratory weakness. Electrophysiological findings have never been described in affected patients (Glover et al., 2014) . Solasonine, larger amounts of solamargine, and other steroidal glycoalkaloids have been isolated in the toxic berry strains. S. torvum poisoning can produce significant neurological and gastrointestinal effects which appear to be mediated by steroidal glycoalkaloids present in the berries (Smith et al., 2008) . Given this toxicity scale, use of this plant part in patients should therefore be avoided.
2.2.9. Spathodea campanulata P. Beauv.
The used of S. campanulata has been reported in the treatment of BU and relief for skin conditions, swollen cheeks, and body rashes. The leaves and stem bark paste are used to bandage ulcers while infusions of the leaves, root and bark are also used to clean ulcers (Adjet et al., 2013; Sam et al., 2013; Addo et al., 2007; Yemoa et al., 2008) . Root decoction showed inhibitory potency on 7 M. ulcerans isolates with MIC value of 25 mg/mL (Table 1) (Addo et al., 2007) . Preliminary phytochemical screening revealed the presence of carbohydrates, alkaloids, tannins, and glycosides in extracts of flowers, and of steroids, carbohydrates, proteins, tannins glycosides and alkaloids in the bark of the plant (Ilodigwe et al., 2010a) . Tannins, saponins, anthraquinone glycosides, and flavonoids were also identified in leaves (Ilodigwe et al., 2010b) . The acute toxicity potential in mice showed an estimated LD 50 of 4500 mg/kg with the ethanolic leaf extract (Ilodigwe et al., 2010a) with no mortality during the period of study but the animals showed signs of anorexia, weakness, sluggishness and significant (p o0.05) reduction in food and water intake and body weight. In the subchronic study, 750-3000 mg/kg of the extract were administered daily for 90 days and showed non-significant effect on haematological parameters while liver biochemical markers transaminases and alkaline phosphatase were increased followed by recovery 28 days post-treatment (Ilodigwe et al., 2010b) .
S. aromaticum is a tree commonly known as clove tree. It is widely used as analgesic and antiseptic primarily in dentistry for its main ingredient eugenol. Reports indicate that it is traditionally used externally or locally for the treatment of minor infections of the mouth and skin, dressing of minor wounds, and BU (Dalziel, 1956; Addo et al., 2007) . In vitro screening of its seeds against M. ulcerans showed MIC value of 25 mg/mL (Table 1) (Addo et al., 2007) . Besides, various studies have been carried out on the chemistry of S. aromaticum revealing that clove buds contain 15-20% essential oil, with high content in eugenol (70-85%), eugenyl acetate (15%) and β-caryophyllene (5-12%). Other reported compounds in clove buds include vanillin, crategolic acid, tannins, gallotannic acid, methyl salicylate, flavonoids, eugenin, kaempferol, rhamnetin, eugenitin and triterpenoids like oleanolic acid (Mittal et al., 2014) . The European Medicines Agency, (2011) reported that acute toxicity of a decoction of clove studied in 30 mice fasted overnight showed no respiratory, gatrointestinal tract, central nervous system symptoms, behavioural patterns and mortality and exhibited LD 50 of 263 mg/kg (i.p.) and 2500 mg/kg (oral). No signs of mortality or gross behavioural changes were observed either after administration of 500 mg/kg of ethanolic extract (DER app. 10:1, ethanol 50%) p.o. Also, a single oral dose of 140 mg/animal killed rats within a short period of time. Other studies also indicated that undiluted clove oil applied on the dorsal skin of hairless mice did not cause irritation. On intact or shaved rabbit skin clove essential oil acted under occlusive conditions as a weak irritant. Phototoxic effects were not observed with undiluted clove oil on hairless mice and pigs. Significant alterations in liver enzymes and haematological parameters were reported after 90 days of administration of a decoction of clove at doses of 300 mg/kg and 700 mg/kg in rats. Even at lower dose, histopathological modifications could be found in body organs. The authors concluded that a prolonged use of decoctions of clove should be avoided. Clove essential oil in oral dosages of 35 or 70 mg per animal (rat) over 8 weeks was tolerated without signs of toxicity. Higher doses led to inactivity and weight loss. About 105 mg/animal p.o. daily for 2 to 3 weeks led to serious liver and kidney damage and death of the animals (European Medicines Agency, 2011). On another hand, all animals died within 24 h after oral administration of 5000 mg/kg of the essential oil in rats and the autopsy showed bleeding in the stomach and intestines, and pleural effusion (European Medicines Agency, 2011). Essential oils are complex lipophilic mixtures that are highly diffusible across cell membranes and might exert significant toxicity effect on organs when taken orally or injected at high undiluted doses. Caution should therefore be paid while using these substances that are otherwise beneficial when used with moderation.
2.2.11. Tonic 1: Mixture of Spigelia anthelmia L. and Zea mays L.
The mixture of Z. mays grain and S. anthelmia leaves reported as used in traditional BU treatment showed growth inhibition of 7 M. ulcerans isolates with MIC values of 6.25-25 mg/mL (Table 1) (Addo et al., 2007 ).
-Spigelia anthelmia L.
S. anthelmia is a common annual weed of cultivation in open re-growths, on unused land in towns (Jegede et al., 2006) . Phytochemical investigation has described the isolation of the alkaloid spiganthine, volatile alkaloids, isoquinoline and actidine isomer, and three quaternary alkaloids, choline, benzoylcholine and 2,3-dimethylacrolyl choline, phenolcarboxylic acids and flavonoids (Maia de Morais et al., 2002) . The acute toxicity study by intraperitoneal administration of the aqueous extract of S. anthelmia showed a LD 50 value of 1140 mg/kg in rats (Jegede et al., 2006) . The ethyl acetate extract also showed LD 50 values of 345.9 mg/kg and 60.8 mg/kg, respectively through oral and intraperitoneal administration in Swiss albino mice (Camurça-Vasconcelos et al., 2004 ). -Zea mays L.
Z. mays corn silk is rich in phenolic compounds, particularly flavonoids. It also contains proteins, vitamins, carbohydrates, calcium, potassium, magnesium and sodium salts, volatile oils and steroids such as sitosterol and stigmasterol, alkaloids, and saponins (Hasanudin et al., 2012) . A 90 days toxicity study using male and female Wistar rats confirmed that Z. mays corn silk is non-toxic in nature with no histopathological and adverse effects observed at 9354 and 10,308 mg/day/kg body wt. respectively (Hasanudin et al., 2012 (Addo et al., 2007) . Z. zanthoxyloides contains essential oils, alkaloids, coumarins, sterols as well as several aliphatic and aromatic amides (Matu, 2011) . Methanolic extract of Z. zanthoxyloides root-bark (cited Fagara zanthoxyloides) showed LD 50 at 5000 mg/kg body weight with signs of cerebral irritation before death and also congestion and focal necrosis of the liver and renal tubules after histopathological examinations of the viscera. Authors however declared the safety of the extract, even if the cerebral mechanism that led to death of the mice needed to be investigated (Ogwal-Okeng et al., 2003) .
Compounds with potency on Mycobacterium ulcerans
Currently, there is only one study that attempted to use isolated active ingredients from plants to treat BU, highlighting the poor emphasis given to research into new chemotherapeutic agents against BU. The authors reported the isolation of four compounds including Holadysamine and three others compound A, B, and C for which chemical structures are yet to be confirmed according to the authors (Yemoa et al., 2015) . Yet the authors tentatively suggested the compounds structures based on LC-MS data on compounds A, B, C combine to bibliographic data on compounds isolated from H. floribunda. They could correspond respectively to holaphyllinol (M W : 331.29), holamine, or holaphyllamine (M W : 315.26), N,N-diméthyl holamine or méthyl holaphylline (M W : 343.29). Further analysis of spectroscopic data on C showed the presence of a fragment at m/z 326 ([M À H 2 Oþ H] þ ) and the loss of a water molecule in its MS/MS fragmentations allowed them to propose an alcoholic and not a ketonic function on C20 (Fig. 4) . Meanwhile Holadysamine showed MIC value of 50 mg/mL against the causative agent of BU, while compounds A, B and C were less active (125 mg/mL).
Conclusion and future perspectives
Among the 98 species reportedly used to treat BU, 7 species were validated through trials in BU patients. In addition, 13 were subjected to further studies supported by pharmacological investigations. Globally, it appears that ethnopharmacological data for this topic is scarce. Also, the reported results of pharmacological investigations highlighted some degree of inconsistency among findings, but also showed promise and indicated that more emphasis should be given to well-planned and coordinated validation studies on all the plants with claimed anti-BU potential. Furthermore, careful attention should be paid while diagnosing BU because it may be confounded with other causes of ulcers especially in rural communities. The gap in knowledge remains huge. Therefore further studies should clearly demonstrate the in vitro and in vivo activities of crude extracts and further characterized fractions, as well as safety in humans.
